地拉罗司去哪买的到？

Maybe many people don’t know much about thalassemia, which is a group of hereditary hemolytic anemia diseases. In recent years, with the increase in incidence, it has gradually entered everyone's field of vision. Currently the best way to treat this disease is through medication. Among them is one of our most effective drugs. Deferasirox is currently the only oral iron chelator developed by Novartis. It was approved by the FDA in November 2005 for use in patients 2 years and older with chronic iron overload caused by blood transfusions. In December 2012, Deferasirox was approved by the European Commission for the treatment of chronic iron overload in patients aged 10 years and older with non-transfusion-dependent thalassemia (NTDT) syndrome who require chelation therapy due to contraindications or insufficiency of deferoxamine mesylate therapy. The U.S. Food and Drug Administration (FDA) approved a new indication for deferasirox on January 23, 2013, for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT). NTDT is a mild form of thalassemia that does not require frequent blood transfusions. But over time, NTDT patients are at risk for iron overload, which can lead to fatal organ damage. The FDA also approved the marketing of FerriScan as an imaging companion diagnostic reagent to deferasirox. The FDA has previously approved FerriScan for the detection of liver iron concentration (LIC), but its use in deferasirox clinical studies is to screen patients for clinical treatment and manage treatment, and its use is limited to imaging and diagnostic reagents necessary for the safe and effective application of deferasirox.

Since Deferasirox has been approved for marketing in China, patients can purchase Deferasirox at large domestic hospitals or pharmacies with a prescription. The only drawback is that the price is relatively high. If the patient chooses the highly cost-effective Indian Cipla Deferasirox, in addition to going to India in person, it can also be obtained through domestic professional overseas medical service institutions. CIPLA (Cipla) is the second largest pharmaceutical company in India with strong financial and scientific research capabilities. Especially its cheap anti-AIDS and anti-cancer drugs are very popular among patients in developing countries. When it comes to Cipla India, patients can choose with confidence.

Recommended related hot articles: /newsDetail/86806.html